Integrated Provider Organizations: Health care delivery systems strive to deliver value in terms clinical outcomes. Value is defined as the highest quality of care that delivers the best outcomes at the lowest possible cost. This dynamic can be seen in the emergence of Accountable Care Organizations (ACOs), bundled payments for certain diseases, and pay-for-results reimbursement models. As a consequence, providers are motivated to leverage solutions that optimize patient outcomes and reduce acute care costs. Quvium can help providers deliver on that value in a number of chronic disease categories.
Health Care Payers: Early adopters of disease management technologies will serve as pilot partners for the Quvium technology. Uptake of the technology is expected to accelerate in the payer market as proof of value data is collected, and the software demonstrates a compelling ROI. Pilots in this marketplace will serve as entry points to larger populations of chronic care patients who are candidates for enrollment in the Quvium technology. The software is both scalable and sustainable – an attractive aspect for any partnership. As more enrollees come onto the system, novel data and analytics re: adherence will yield a high market value.
Pharmaceutical Industry: Drug companies, pharmacy benefits management organizations and retail pharmacies are vested in enhancing patient engagement and improving adherence to medication regimens. When adherence to treatment plans improves, outcomes improve. Quvium will partner with pharma manufacturers and service industries to accelerate adoption in the market place. Everybody wins when patients engage and understand the value of following their clinician’s treatment recommendations.
Disease Management Industry: This industry sells integrative care services that reduce complications associated with chronic diseases, improve the quality of life and reduce health care costs. Quvium will partner with select value-added resellers in order to promote its platform to their core customer base of payers.
Non-Profit Organizations & Government: Quvium is enlisting non-profit organizations to collaborate on improving the lives of chronic illness sufferers. This includes patient advocacy organizations, philanthropic organizations, disease-focused associations and others. Because asthma is the most common chronic condition of children in the U.S., federal and state funding is available for programs designed to improve the care management of children with asthma. Program and grant funding will be accessed to help pay for children without coverage who qualify for Quvium’s asthma solution. Quvium’s mission is not only to support adherence to care protocols, but to enable its technology to reach underserved children with asthma – specifically, children of low socioeconomic status, those exposed to urban environmental contaminants, children with limited access to medical care and families with sub-optimal asthma care management skills.